Replimune Group, Inc. (REPL)
7.30
-0.41
(-5.32%)
USD |
NASDAQ |
Jan 15, 16:00
7.31
+0.01
(+0.14%)
After-Hours: 20:00
Replimune Group SG&A Expense (TTM): 102.36M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Rapt Therapeutics, Inc. | 29.76M |
| Olema Pharmaceuticals, Inc. | 18.61M |
| CorMedix, Inc. | 75.56M |
| Verastem, Inc. | 67.48M |
| Anavex Life Sciences Corp. | 13.82M |